Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Attanoos

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Histopathology|August 10, 2000
Primary malignant gonadal mesotheliomas and asbestosR L Attanoos, A R Gibbs
Histopathology|May 1, 1997
Pathology of malignant mesotheliomaR L Attanoos, A R Gibbs
Histopathology|November 26, 2003
'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, CardiffR L Attanoos, A R Gibbs
Histopathology|October 8, 2004
The pathology associated with therapeutic procedures in malignant mesotheliomaR L Attanoos, A R Gibbs
Journal of Clinical Pathology|August 29, 2000
acp. Best practice no 161. Examination of lung specimensA R Gibbs, R L Attanoos
Histopathology|July 24, 2008
The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesotheliomaR L Attanoos, A R Gibbs
Histopathology|September 1, 1996
Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesotheliomaR L Attanoos, H Goddard, A R Gibbs
Histopathology|August 28, 2003
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2R L Attanoos, A Griffin, A R Gibbs
Histopathology|March 1, 1997
CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinomaR L Attanoos, R Webb, A R Gibbs
Histopathology|August 1, 1996
Thrombomodulin as a marker of vascular and lymphatic tumoursM A Appleton, R L Attanoos, B Jasani
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Histopathology|August 10, 2000
Primary malignant gonadal mesotheliomas and asbestosR L Attanoos, A R Gibbs
Histopathology|May 1, 1997
Pathology of malignant mesotheliomaR L Attanoos, A R Gibbs
Histopathology|November 26, 2003
'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, CardiffR L Attanoos, A R Gibbs
Histopathology|October 8, 2004
The pathology associated with therapeutic procedures in malignant mesotheliomaR L Attanoos, A R Gibbs
Journal of Clinical Pathology|August 29, 2000
acp. Best practice no 161. Examination of lung specimensA R Gibbs, R L Attanoos
Histopathology|July 24, 2008
The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesotheliomaR L Attanoos, A R Gibbs
Histopathology|September 1, 1996
Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesotheliomaR L Attanoos, H Goddard, A R Gibbs
Histopathology|August 28, 2003
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2R L Attanoos, A Griffin, A R Gibbs
Histopathology|March 1, 1997
CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinomaR L Attanoos, R Webb, A R Gibbs
Histopathology|August 1, 1996
Thrombomodulin as a marker of vascular and lymphatic tumoursM A Appleton, R L Attanoos, B Jasani
Pageof 3